DOCK10 Triggers Dangerous Insulin Hypersecretion in Rare Pancreatic Tumors
Researchers have identified DOCK10 as a critical molecular trigger driving excessive insulin release in rare pancreatic tumors. This discovery offers a modern potential therapeutic target for managing insulinomas. Patients suffering ... Read More